2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in United States Leader Award
1991 - Fellow of the American Heart Association
1990 - Fellow of the American Statistical Association (ASA)
His primary scientific interests are in Internal medicine, Framingham Heart Study, Risk factor, Endocrinology and Framingham Risk Score. Ralph B. D'Agostino interconnects Diabetes mellitus, Surgery and Cardiology in the investigation of issues within Internal medicine. His work carried out in the field of Framingham Heart Study brings together such families of science as Gerontology, Stroke, Proportional hazards model, Atrial fibrillation and Cohort.
His study looks at the relationship between Proportional hazards model and topics such as Hazard ratio, which overlap with Gastroenterology. The various areas that Ralph B. D'Agostino examines in his Risk factor study include Odds ratio, Relative risk, Fibrinogen, Myocardial infarction and Vascular disease. His Framingham Risk Score research is multidisciplinary, relying on both Offspring, Epidemiology, Demography, Prospective cohort study and Risk assessment.
His scientific interests lie mostly in Internal medicine, Framingham Heart Study, Cardiology, Endocrinology and Framingham Risk Score. His Internal medicine study combines topics in areas such as Diabetes mellitus and Surgery. His Framingham Heart Study research focuses on subjects like Proportional hazards model, which are linked to Hazard ratio.
His work on Cardiology is being expanded to include thematically relevant topics such as Disease. The study incorporates disciplines such as Offspring, Odds ratio, Demography, Prospective cohort study and Risk assessment in addition to Framingham Risk Score. Risk factor connects with themes related to Incidence in his study.
Ralph B. D'Agostino mainly investigates Internal medicine, Cardiology, Diabetes mellitus, Cohort and Framingham Risk Score. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology. His Cardiology study incorporates themes from Prospective cohort study, Chemotherapy and Blood pressure.
His studies in Cohort integrate themes in fields like Surgery, Epidemiology, Cohort study, Disease and Hazard ratio. Ralph B. D'Agostino has included themes like Cholesterol and Risk assessment in his Framingham Risk Score study. His research integrates issues of Offspring, Agatston score, Proportional hazards model and Risk factor in his study of Framingham Heart Study.
Ralph B. D'Agostino mostly deals with Internal medicine, Cardiology, Framingham Risk Score, Cohort and Framingham Heart Study. His Internal medicine research includes themes of Diabetes mellitus, Endocrinology and Surgery. He usually deals with Diabetes mellitus and limits it to topics linked to Body mass index and Odds ratio.
His Cardiology research integrates issues from Renal artery, Kidney and Renal Artery Obstruction. His Framingham Risk Score research is multidisciplinary, incorporating perspectives in Cohort study, Coronary artery disease, Cholesterol, Risk assessment and Risk factor. His work deals with themes such as Demography, Proportional hazards model and Hazard ratio, which intersect with Framingham Heart Study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prediction of Coronary Heart Disease Using Risk Factor Categories
Peter W. F. Wilson;Ralph B. D’Agostino;Daniel Levy;Albert M. Belanger.
Circulation (1998)
Propensity score methods for bias reduction in the comparison of a treatment to a non‐randomized control group
Ralph B. D’Agostino.
Statistics in Medicine (1998)
General Cardiovascular Risk Profile for Use in Primary Care The Framingham Heart Study
Ralph B. D’Agostino;Ramachandran S. Vasan;Michael J. Pencina;Philip A. Wolf.
Circulation (2008)
The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function
R. Rosen;Candace Brown;J. Heiman;S. Leiblum.
Journal of Sex & Marital Therapy (2000)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J Pencina;Ralph B D'Agostino;Ramachandran S Vasan.
Statistics in Medicine (2008)
Impact of Atrial Fibrillation on the Risk of Death The Framingham Heart Study
Emelia J. Benjamin;Philip A. Wolf;Ralph B. D’Agostino;Halit Silbershatz.
Circulation (1998)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff;Donald M. Lloyd-Jones;Glen Bennett;Sean Coady.
Journal of the American College of Cardiology (2014)
TUTORIAL IN BIOSTATISTICS PROPENSITY SCORE METHODS FOR BIAS REDUCTION IN THE COMPARISON OF A TREATMENT TO A NON-RANDOMIZED CONTROL GROUP
Ralph B. D'agostino.
(1998)
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study
F. Javier Nieto;Terry B. Young;Bonnie K. Lind;Eyal Shahar.
JAMA (2000)
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Sudha Seshadri;Alexa Beiser;Jacob Selhub;Paul F Jacques.
The New England Journal of Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Boston University
Boston University
Duke University
Boston University
National Institutes of Health
Boston University
Emory University
National Institutes of Health
Boston University
Boston University
Nvidia (United States)
University of Ulster
Sungkyunkwan University
Lawrence Berkeley National Laboratory
University of Namur
University of Lausanne
Pontificia Universidad Católica de Chile
Temple University
University of California, Berkeley
Beth Israel Deaconess Medical Center
University of Iceland
University of Massachusetts Lowell
Ludwig-Maximilians-Universität München
University Medical Center Groningen
Novartis (Switzerland)
Harvard University